检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]四川大学华西医院心血管内科,成都610041
出 处:《医学综述》2015年第3期464-466,共3页Medical Recapitulate
摘 要:心脏再同步治疗(CRT)在心力衰竭治疗方面的效果已被广泛证实。随着指南的更新,其治疗的适应证范围不断扩大,更多患者将从中受益。但研究证明,仍有近30%的患者表现为CRT无应答。由于目前还没有统一的、被普遍认可的CRT应答评估标准,CRT治疗效果的评价仍较为混乱。越来越多的研究致力于提高CRT应答率,以更好地预测患者的预后,帮助临床决策。该文试图通过分析总结目前有关CRT无应答的原因,探寻最优的应答评估标准和更好的引导程控优化的方法,为提高CRT应答率提供参考依据。The effects of cardiac resynchronization therapy( CRT) in the treatment for heart failure have been widely confirmed. As the guideline updates,indication range of CRT has been expanded,which will benefit more patients. But some studies have shown that there are still nearly 30% of the patients having no response to CRT. Because there has not been any generally accepted CRT response evaluation standard,the evaluation on the effect of CRT treatment is still relatively confused. Therefore,more and more researches have been committed to increase the CRT response rate in order to improve the prognosis. Here is to make a review of the recent research findings of the reasons for no response to CRT,so as to provide reference for finding the optimal response assessment criteria and better control method after operation,and improve the Cardiac resynchronization therapy response rate.
关 键 词:心脏再同步治疗 左心室起搏 心脏再同步治疗应答 程控优化
分 类 号:R541.61[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.200